Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML

LODHI, Yusuf, Adriana LADUNGOVÁ, Daniel BUŠA, Helena PESCHELOVÁ, Martin ČULEN and Michal ŠMÍDA. Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML. In Annual PhD conference Biomedical sciences, Brno. 2022.

Basic information

Original name

Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML

Authors

LODHI, Yusuf, Adriana LADUNGOVÁ, Daniel BUŠA, Helena PESCHELOVÁ, Martin ČULEN and Michal ŠMÍDA

Edition

Annual PhD conference Biomedical sciences, Brno, 2022

---

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology

Tags

NÚVR_CEITEC

---

Links

LX22NPO5102, research and development project	Name: Národní ústav pro výzkum rakoviny (Acronym: NÚVR) Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES
MUNI/A/1330/2021, interní kód MU	Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IX (Acronym: VýDiTeHeMa IX) Investor: Masaryk University